Furthermore, by revealing the role of the AR-FOXL2-aromatase axis in granulosa cell estrogen synthesis, our findings not only validate these clinical observations but also provide potential new therapeutic insights for targeting this pathway, establishing a strong scientific foundation for letrozole as a treatment option for ovulation induction in PCOS patients. Here, FOXL2 is linked to polycystic ovary syndrome.